During the past decade, Ospedale San Filippo Neri conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Filippo Neri" #1 sponsor was "San Filippo Neri General Hospital" with 5 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Azienda Ospedaliera Cardinale G. Panico" with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored and "European Institute of Oncology" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Filippo Neri" #1 collaborator was "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator, "Biotronik Italia" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Filippo Neri" are "Atrial Fibrillation" (3 trials), "Breast Cancer" (3 trials), "Lung Cancer" (3 trials), "Aneurysm" (2 trials) and "Chronic Stable Angina" (2 trials). Many other conditions were trialed in "Ospedale San Filippo Neri" in a lesser frequency.

Most popular intervention types in "Ospedale San Filippo Neri" are "Drug" (15 trials), "Device" (11 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "cisplatin" (3 trials), "etoposide" (2 trials), "5-Fluorouracil" (1 trials) and "Adalimumab (40 mg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Filippo Neri" are 35 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale San Filippo Neri". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Ospedale San Filippo Neri, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Filippo Neri, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".